Hypersensitivity to CGRP as a predictive biomarker of migraine prevention with erenumab.
Al-Khazali HM, Ashina H, Christensen RH, Wiggers A, Rose K, Iljazi A, Amin FM, Ashina M, Snellman J, Maio-Twofoot T, Schytz HW.
Al-Khazali HM, et al. Among authors: ashina h.
Cephalalgia. 2024 Jun;44(6):3331024241258734. doi: 10.1177/03331024241258734.
Cephalalgia. 2024.
PMID: 38859744
Free article.
Clinical Trial.